DSM-Firmenich AG
F:ZX6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
DSM-Firmenich AG
F:ZX6
|
CH |
|
T
|
Tosoh Corp
XMUN:TOS
|
JP |
|
P
|
Prologis Inc
BMV:PLD
|
US |
Intrinsic Value
The intrinsic value of DSM-Firmenich AG (ZX6) under the Base Case is 58.76 EUR per share. Compared with the current market price of 109.1 EUR, the stock appears Overvalued by 46% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What DSM-Firmenich Does
DSM-Firmenich makes ingredients, aromas, and nutritional products that go into everyday consumer goods. It sells fragrance ingredients and perfume compounds for personal care and home care brands, flavorings for food and drinks, and vitamins, enzymes, and other nutrition ingredients used in supplements, animal feed, and some healthcare products.
- Headquarters
- Switzerland CH
- Employees
- 26 873
- IPO date
- Apr 18, 2023
DSM-Firmenich has no economic moat
Customers have competing suppliers for flavors, fragrances and nutritional ingredients, so DSM-Firmenich must keep winning business through product quality, innovation and price. Its technical expertise and patents help individual products stand out, but do not prevent rivals from offering alternatives across its markets.
Read the full moat analysis
Revenue & Expenses Breakdown
DSM-Firmenich AG
Earnings Waterfall
DSM-Firmenich AG
The intrinsic value for DSM-Firmenich AG (ZX6) under the Base Case is 58.76 EUR.
Compared with the current market price of 109.1 EUR, the stock appears Overvalued by 46% .